Committee on the Safety of Medicines
Encyclopedia
The Committee on the Safety of Medicines (CSM) was an independent advisory committee that for 40 years advised the UK
Licensing Authority on the quality, efficacy and safety of medicines
.
Following the thalidomide
tragedy of 1957 to 1961, in 1963 the government asked Sir Derrick Dunlop to set up a committee to investigate the control and introduction of new medicines in to the United Kingdom. As a result of the subsequent report to the Department of Health, which reinforced the need for specially trained doctors in the pharmaceutical industry and academic departments of medicine, Dunlop became the first chairman of the committee.
It was replaced on 30 October 2005 by the Commission on Human Medicines
which combines the functions of both the former committee and the Medicines Commission.
United Kingdom
The United Kingdom of Great Britain and Northern IrelandIn the United Kingdom and Dependencies, other languages have been officially recognised as legitimate autochthonous languages under the European Charter for Regional or Minority Languages...
Licensing Authority on the quality, efficacy and safety of medicines
Medication
A pharmaceutical drug, also referred to as medicine, medication or medicament, can be loosely defined as any chemical substance intended for use in the medical diagnosis, cure, treatment, or prevention of disease.- Classification :...
.
Following the thalidomide
Thalidomide
Thalidomide was introduced as a sedative drug in the late 1950s that was typically used to cure morning sickness. In 1961, it was withdrawn due to teratogenicity and neuropathy. There is now a growing clinical interest in thalidomide, and it is introduced as an immunomodulatory agent used...
tragedy of 1957 to 1961, in 1963 the government asked Sir Derrick Dunlop to set up a committee to investigate the control and introduction of new medicines in to the United Kingdom. As a result of the subsequent report to the Department of Health, which reinforced the need for specially trained doctors in the pharmaceutical industry and academic departments of medicine, Dunlop became the first chairman of the committee.
It was replaced on 30 October 2005 by the Commission on Human Medicines
Commission on Human Medicines
The Commission on Human Medicines is a committee of the UK's Medicines and Healthcare products Regulatory Agency. It was formed in October 2005 by the amalgamation of the Medicines Commission and the Committee on Safety of Medicines....
which combines the functions of both the former committee and the Medicines Commission.